Showing results (31-40 of 657) with videos related to
Sort By:
Pageof 66
Journal of the American College of Cardiology|May 1, 1996
Late assessment of thrombolytic efficacy (LATE) study: prognosis in patients with non-Q wave myocardial infarction. (LATE Study Investigators)A Langer, S G Goodman, E J Topol, et al.The Canadian Journal of Cardiology|October 1, 1996
Evolution of the CCU from rhythm, function and protection to reperfusion and beyond: a personal journey and perspectiveP W ArmstrongEuropean Heart Journal|September 1, 1996
Perspectives gained from large-scale thrombolytic comparative trialsP W ArmstrongEuropean Heart Journal|May 1, 1996
Non-invasive prediction of reperfusion and coronary artery patency by continuous ST segment monitoring in the GUSTO-I trialP Klootwijk, A Langer, S Meij, et al.Journal of the American College of Cardiology|June 1, 1995
Noninvasive assessment of speed and stability of infarct-related artery reperfusion: results of the GUSTO ST segment monitoring study. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary ArteriesA Langer, M W Krucoff, P Klootwijk, et al.Journal of the American College of Cardiology|April 3, 1998
Prognostic significance of ST segment shift early after resolution of ST elevation in patients with myocardial infarction treated with thrombolytic therapy: the GUSTO-I ST Segment Monitoring SubstudyA Langer, M W Krucoff, P Klootwijk, et al.The American Journal of Medicine|November 1, 1986
Influence of skin site on bioavailability of nitroglycerin ointment in congestive heart failureG Moe, P W ArmstrongCanadian Medical Association Journal|July 22, 1978
Preservation of pre-excitation despite acute myocardial infarction complicated by complete heart blockK Boroomand, P W ArmstrongJournal of Cardiovascular Pharmacology|November 1, 1990
Pacing-induced heart failure in the dog: evaluation of peripheral vascular alpha-adrenoceptor subtypesC Forster, P W ArmstrongJournal of the American College of Cardiology|June 1, 1989
Tissue plasminogen activator: Toronto (TPAT) placebo-controlled randomized trial in acute myocardial infarctionP W Armstrong, R S Baigrie, P A Daly, et al.Pageof 66